B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Mli 2

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Mli 2, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

dnl
2 shared targets
oxybutynin
3 shared targets
diphenhydramine
3 shared targets
clemastine
4 shared targets
methapyrilene
3 shared targets
carbetapentane
2 shared targets
lorecivivint
2 shared targets
skepinone
2 shared targets
demethylbellidifolin
2 shared targets
bay
4 shared targets
Loading evidence profile...

This evidence profile for Mli 2 is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.